Clinical Trial Update: The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer

View source ↗

Summary

The document outlines a clinical trial evaluating the role of HE4 as a follow-up biomarker for advanced ovarian, fallopian tube, and primary peritoneal cancers.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Brno University Hospital | Conditions: Ovarian Neoplasms | Status: UNKNOWN